Circio

Business Services · Norway · 1-10 Employees

View Company Info for Free

Overview

Headquarters

St. Olavs Plass, Oslo, Oslo, 0130, Norwa...

Phone Number

+47 92951788

Revenue

-

Stock Symbol

CRNA.OL

Industry

Business Services Research & Development
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1

About Circio

Circio Holding ASA (OSE: CRNA) is a biotechnology company developing novel circular RNA and immunotherapy medicines. Circio Holding ASA is a biotechnology company developing novel circular RNA and immunotherapy medicines. Circio has established a unique circular RNA (circRNA) platform to develop novel circRNA medicines for rare disease, vaccines, and cancer. The proprietary circVec technology is based on a modular genetic cassette design for efficient biogenesis of multifunctional circRNA from DNA and viral vectors, which can be deployed for many purposes. The circVec platform has demonstrated enhanced and more durable protein expression than classic mRNA vector systems, and has the potential to become the new gold-standard for DNA and virus-based therapeutics in the future. The circRNA R&D activities are being conducted by the wholly owned subsidiary Circio AB based at the Karolinska Institute in Stockholm, Sweden.Explore more
Circio's Social MediaPopular SearchesCircio Holding ASACircio ABSIC Code 87,873NAICS Code 54,541Ticker STO: CRNA.OLShow more

Is Circio your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Illustration of an envelope

Company Profile Activity

i

Among all Business Services companies

Low Activity

High Activity

Activity Insights

Circio is experiencing very low activity levels compared to other companies in the Business Services sector.

What does this means?

Circio is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Circio.

Circio financials insights

Gather financial insights about Circio, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.

2024

Share Placement

$4.5M

2026

Share Issuance

$31.5M

See All Circio's Financials Insights

Circio Tech Stack

A closer look at the technologies used by Circio

Most Recent Scoops

Person-Based
Bioengineering, Medical Research
Person-Based
Partnership, Bioengineering, Medical Research
Person-Based
Partnership, Medical Research
Person-Based
Partnership, Research & Development, Bioengineering
Funding
Funding
See more scoops

Top Business Services Companies

Frequently Asked Questions Regarding Circio

What is Circio's stock symbol?
Circio's stock symbol is CRNA.OL
What is Circio's official website?
Circio's official website is www.circio.com
What is Circio's SIC code?
Circio's SIC: 87,873
What is Circio's NAICS code?
Circio's NAICS: 54,541
How many employees does Circio have?
Circio has 1-10 employees
What industry does Circio belong to?
Circio is in the industry of: Business Services, Research & Development
What companies has Circio acquired?
Circio has acquired the companies: Oncos Therapeutics
What technology does Circio use?
Some of the popular technologies that Circio uses are: WordPress.org, PHP, Cloudflare Website Optimization, Cloudflare CDN
How do I contact Circio?
Circio contact info: Phone number: +47 92951788 Website: www.circio.com
What does Circio do?

Circio Holding ASA (OSE: CRNA) is a biotechnology company developing novel circular RNA and immunotherapy medicines. Circio Holding ASA is a biotechnology company developing novel circular RNA and immunotherapy medicines. Circio has established a unique circular RNA (circRNA) platform to develop novel circRNA medicines for rare disease, vaccines, a... nd cancer. The proprietary circVec technology is based on a modular genetic cassette design for efficient biogenesis of multifunctional circRNA from DNA and viral vectors, which can be deployed for many purposes. The circVec platform has demonstrated enhanced and more durable protein expression than classic mRNA vector systems, and has the potential to become the new gold-standard for DNA and virus-based therapeutics in the future. The circRNA R&D activities are being conducted by the wholly owned subsidiary Circio AB based at the Karolinska Institute in Stockholm, Sweden.Read More

What are Circio social media links?
Circio Linkedin page Circio Twitter page Circio Facebook page
Is Circio a public company?
Yes, Circio is a public company and is traded under the symbol CRNA.OL
See more information about Circio

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.